Pharmaceuticals and Their Increased Risk of Birth Defects
Though pharmaceutical drugs are developed in order to benefit our health, negligence and malpractice on behalf of doctors or drug manufacturers themselves can often lead to several unfortunate adverse effects. Sadly, one common area in which this is most evident is in the area of congenital birth defects.
One recent example of a drug that leads to birth defects is Zofran. Though safe if used properly, “off-label” prescriptions as well as misleading marketing practices have led to the FDA issuing warnings regarding this drug’s association to several birth defects.
According to the website of Williams Kherkher, a firm that has had plenty of experience with cases involving Zofran, Ondansetron, the generic name for Zofran, can lead to several congenital heart defects as well as orofacial clefts. Unfortunately, Zofran, which was originally approved for the treatment of nausea and vomiting in cancer and post-surgery patients, is often prescribed “off-label” to pregnant women who experience similar symptoms.
Sadly, certain medications are not the only risk that unborn and newborn children face. For example, newborn children also run the risk of developing cerebral and Erb’s palsy. According to the website of the Chicago cerebral palsy attorneys at the Driscoll firm, cerebral and Erb’s palsy are often caused by negligence on behalf of medical professionals. Failure to uphold medical standards by pulling the baby’s head at the wrong time, using medical tools inappropriately, or pulling too hard on the shoulders can often lead to a child’s development of cerebral or Erb’s Palsy.